SB540 • 2025

Requires a drug manufacturer or wholesaler to state on the label of an orally administered drug any ingredients derived from gluten-containing grains.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor: Senator Sollman
Last action: 2025-06-27
Official status: In Senate Committee
Effective date: Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Requires a drug manufacturer or wholesaler to state on the label of an orally administered drug any ingredients derived from gluten-containing grains.

Digest: The Act says that drug labels need to list the ingredients made from gluten-containing grains.

What This Bill Does

Digest: The Act says that drug labels need to list the ingredients made from gluten-containing grains.
(Flesch Readability Score: 67.5).
Requires a drug manufacturer or wholesaler to state on the label of an orally administered drug any ingredients derived from gluten-containing grains.
Takes effect on the 91st day following adjournment sine die.

Limits and Unknowns

This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

2025-06-27 Senate
In committee upon adjournment.
2025-01-17 Senate
Referred to Health Care.
2025-01-13 Senate
Introduction and first reading. Referred to President's desk.

Official Summary Text

Digest: The Act says that drug labels need to list the ingredients made from gluten-containing grains. (Flesch Readability Score: 67.5).
Requires a drug manufacturer or wholesaler to state on the label of an orally administered drug any ingredients derived from gluten-containing grains.
Takes effect on the 91st day following adjournment sine die.
Relating to: Relating to drug labeling requirements; prescribing an effective date.
Current location: In Senate Committee

Current Bill Text

Read the full stored bill text

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
83rd OREGON LEGISLATIVE ASSEMBLY--2025 Regular Session
Senate Bill 540
Sponsored by Senator SOLLMAN (Presession filed.)
SUMMARY
The following summary is not prepared by the sponsors of the measure and is not a part of the body thereof subject
to consideration by the Legislative Assembly. It is an editor’s brief statement of the essential features of the
measure as introduced. The statement includes a measure digest written in compliance with applicable readability
standards.
Digest: The Act says that drug labels need to list the ingredients made from gluten-containing
grains. (Flesch Readability Score: 67.5).
Requires a drug manufacturer or wholesaler to state on the label of an orally administered drug
any ingredients derived from gluten-containing grains.
Takes effect on the 91st day following adjournment sine die.
A BILL FOR AN ACT
Relating to drug labeling requirements; and prescribing an effective date.
Be It Enacted by the People of the State of Oregon:
SECTION 1.
Section 2 of this 2025 Act is added to and made a part of ORS chapter 689.
SECTION 2. (1) As used in this section, “gluten-containing grain” means any of the fol-
lowing grains or a crossbred hybrid of any of the following grains:
(a) Wheat and any species belonging to the genus Triticum;
(b) Rye and any species belonging to the genus Secale;
(c) Barley and any species belonging to the genus Hordeum; or
(d) Oat and any species belonging to the genus Avena sativa.
(2) A manufacturer or wholesaler subject to ORS 689.305 may not sell or otherwise dis-
tribute, or offer to sell or otherwise distribute, an orally administered drug that contains an
ingredient derived from a gluten-containing grain unless the drug parcel, package or con-
tainer bears a label stating that the drug contains the gluten-containing grain and identifying
the ingredient and type of gluten-containing grain from which the ingredient is derived.
SECTION 3.
(1) Section 2 of this 2025 Act becomes operative on January 1, 2028.
(2) The State Board of Pharmacy may take any action prior to the operative date speci-
fied in subsection (1) of this section that is necessary to enable the board to exercise, on and
after the operative date specified in subsection (1) of this section, all of the duties, functions
and powers conferred on the board by section 2 of this 2025 Act.
SECTION 4. This 2025 Act takes effect on the 91st day after the date on which the 2025
regular session of the Eighty-third Legislative Assembly adjourns sine die.
NOTE: Matter in boldfaced type in an amended section is new; matter [ italic and bracketed] is existing law to be omitted.
New sections are in boldfaced type.
LC 3321